1.Analyzing the Operation Efficiency of Specialized Hospitals in Guangdong from 2009 to 2014
Juan ZHOU ; Qiu ZHANG ; Hui ZHANG
Chinese Health Economics 2017;36(6):87-89
Objective:To analyze the operational efficiency of public specialized hospitals and private specialized hospitals in Guangdong.Methods:Using the Malmquist index model of DEA to analyze operational efficiency of public specialized hospitals and private specialized hospitals in Guangdong from 2010 to 2015.Results:From 2010 to 2015,the overall operation efficiency of specialized hospitals were in low condition;the operational efficiency of public specialized hospitals was better than private specialized hospitals.Conclusion:Medical and health reform policy should attach great importance to the construction of specialized subject hospitals.Private specialized hospital was the cornucopia of hospital development which needed accurate and professional.
2.A systematic review of MA versus IA regimen for patients with acute myelogenous leukemia.
Wen-juan WANG ; Ai-ning SUN ; Hui-ying QIU
Chinese Journal of Hematology 2011;32(12):869-870
Adolescent
;
Adult
;
Antineoplastic Combined Chemotherapy Protocols
;
adverse effects
;
therapeutic use
;
Child
;
Cytarabine
;
administration & dosage
;
Daunorubicin
;
administration & dosage
;
adverse effects
;
Female
;
Humans
;
Leukemia, Myeloid, Acute
;
drug therapy
;
Male
;
Middle Aged
;
Mitoxantrone
;
administration & dosage
;
adverse effects
;
Young Adult
4.Thyroid hormone changes in women with pre-eclampsia and its relationship with the presence of preeclampsia
Jiaren ZHOU ; Juan DU ; Bing MA ; Xuemin LIU ; Hui QIU ; Jie LI ; Xuejiao WANG
Chinese Journal of Obstetrics and Gynecology 2014;49(2):109-113
Objective To study thyroid hormone changes in women with pre-eclampsia patients,the characteristics of thyroid disease and its relationship with pre-eclampsia.Methods From May 2011 to December 2012 171 patients with pre-eclampsia who delivered in Shengjing Hospital of China Medical University were recruited as prc-eclampsia(PE) group,among which 114 cases were defined as early onset pre-eclampsia (EP) group and 57 cases were defined as late onset pre-eclampsia (LP) group.And 171 healthy women with same age and same stage of pregnancy were selected as the control group.Their blood pressures were normal and they had no obstetrical complications.Serum thyrotropin (TSH),free triiodothyronine (FT3) and free thyroxine (FT4) levels were determined by solid-phase chemiluminescent enzyme immunoassay method (CMIA).Thyroid peroxidase antibody (TPOAb) and thyroglobulin antibody (TGAb) were measured by electro-chemiluminescent assay (ECLIA).The positive rate was calculated (TPOAb > 5.6 U/L,TGAb > 4.1 U/L were defined as positive result).The relationship between TSH,FT3,FT4 level and blood pressure was analyzed in women with pre-eclampsia.Results (1) The median values of TSH,FT4 and FT3 in PE group were 3.4 mU/L,(12.0 ± 3.0) pmol/L and(3.9 ± 0.9) pmol/L.In the control group,they were 1.9 mU/L,(13.4 ± 2.4) and (5.0 ± 1.3) pmol/L.There were statistically significant differences between the two groups(P < 0.01).In EP group,the median values of TSH,FT4 and FT3 were 3.3 mU/L,(12.1 ± 3.4) pmol/L and (3.8 ± 0.9) pmol/L.The differences between EP group and the control group were statistically significant (P < 0.01).In LP group,the median values of TSH,FT4 and FT3 were 3.4 mU/L,(11.9 ± 3.1) pmol/L and (3.9 ± 1.0) pmol/L.There were statistically significant differences compared to the control group(P <0.01).While there was no difference between EP group and LP group (P > 0.05).(2) The positive rate of TPOAb and TGAb in PE group were 15.2% (26/171)and 21.6% (37/171),and were 12.3% (21/171) and 14.6% (25/171) in the control group.There was statistically significant difference in the TGAb positive rate (P < 0.01),but the difference in TPOAb positive rate was not statistically different(P >0.05).The TPOAb positive rates in EP group and LP group were 12.3 % (14/114) and 21.1% (12/57),respectively,with no statistically significant difference (P > 0.05).And the positive rates of TGAb in EP group and LP group were 21.9% (25/114)and 21.1% (12/57),respectively,with no statistically significant difference(P > 0.05).The positive rate of TPOAb in LP group and in the control group had statistically significant difference(P <0.01).(3) The morbidity of thyroid disease in PE group and in the control group were 47.4% (81/171) and 16.4% (28/171),with statistically significant difference (P < 0.01).(4) The morbidity of subclinical hypothyroidism or hypothyroidism in PE group and in the control group were 45.0% (77/171) and 16.4% (28/171),with statistically significant difference(P <0.01).(5) The morbidity of subclinical hyperthyroidism in PE group and in the control group were 2.3 % (4/171) and 1.8 % (3/171),with no statistically significant difference (P>0.05).(6) In PE group,women with TSH level of 0.3-3.3 mU/L had systolic pressure of(170 ± 21)mmHg (1mmHg =0.133 kPa)and diastolic pressure of(112 ± 15) mmHg; women with TSH > 3.3 mU/L had systolic pressure of(166 ± 21)mmHg and diastolic pressure of(109 ± 13)mmHg.There was no statistically significant difference(P > 0.05).But the diastolic pressure in EP group and LP group had statistically significant difference(P < 0.01).In PE group,no correlation was found among TSH,FT4 levels and systolic pressure,diastolic pressure(P > 0.05).FT3 level was negatively correlated to diastolic pressure (r =-0.172,P =0.023).Conclusions It is common that pre-eclampsia is complicated with thyroid dysfunction,mainly subclinical hypothyroidism.Thus it is nessesary to test thyroid hormone and thyroid antibodies in women with pre-eclampsia.The decrease of FT3 and FT4,the increase of TSH and the presence of TPOAb and TGAb are related with the presence of pre-eclampsia.
5.Comparative analysis of abnormal thin-layer cytologic diagnosis, hybrid capture II HPV DNA testing results and histologic diagnosis in 2225 patients.
Ai-chun WANG ; Yi-qun GU ; Jun WANG ; Qiu-li ZHOU ; Li WANG ; Li-juan LU ; Hui ZHANG
Chinese Journal of Pathology 2011;40(1):46-47
Adult
;
Aged
;
Carcinoma, Squamous Cell
;
pathology
;
virology
;
Cervical Intraepithelial Neoplasia
;
pathology
;
virology
;
Colposcopy
;
Cytodiagnosis
;
DNA Probes, HPV
;
DNA, Viral
;
isolation & purification
;
Female
;
Humans
;
Middle Aged
;
Nucleic Acid Hybridization
;
Papillomaviridae
;
genetics
;
isolation & purification
;
Papillomavirus Infections
;
Uterine Cervical Neoplasms
;
pathology
;
virology
;
Vaginal Smears
;
Young Adult
6.Optimization for vacuum belt drying process of Qibai Pingfei granule through response surface methodology.
Xue-feng LI ; Zhen-qiu XU ; Ming YAN ; Jing SHANG ; Yan-jun ZHANG ; Hui-juan MI ; Wei XIAO
China Journal of Chinese Materia Medica 2015;40(20):3987-3992
Based on single factor tests,the optimum vacuum belt drying conditions of Qibai Pingfei granule were obtained through Box-Benhnken central combination design and RSM. In this study, drying time, drying temperature and extract density were chosen as independent variables, while transferring rate ginsenoside Rg₁, Re, Rb₁and astragaloside IV were taken as dependent variables. The optimum parameters are as follows: drying time of 112 min, drying temperature of 87 °C and extract density of 1.30 g · mL⁻¹. At the optimum condition, transferring rate ginsenoside Rg₁+ Re, Rb₁and astragaloside IV were 88.01%, 87.31%, 84. 34%. Above all, the optimum processing parameters of vacuum belt drying of Qibai Pingfei granule is reasonable and feasible, which can provide reliable basis for production.
Chemistry, Pharmaceutical
;
instrumentation
;
methods
;
Desiccation
;
instrumentation
;
methods
;
Drugs, Chinese Herbal
;
chemistry
;
Plants, Medicinal
;
chemistry
;
Quality Control
;
Temperature
;
Vacuum
7.Cervical spondylosis of vertebral artery treated with thermosensitive moxibustion with different dosages: a randomized controlled trial.
Xiao-Ping ZHOU ; Hua LIN ; Yong FU ; Xiao-Yong WAN ; Peng FANG ; Jian-Yong JIE ; Chun-Lin QIU ; Hui-Ping WU ; Juan-Juan ZHOU
Chinese Acupuncture & Moxibustion 2014;34(5):461-464
OBJECTIVETo compare the difference in the clinical efficacy on cervical spondylosis of vertebral artery type (CSA) treated with thermosensitive moxibustion at different dosages.
METHODSSixty cases of CSA were randomized into a saturated moxa dosage group and a regular moxa dosage group, 30 cases in each one. The thermosensitive moxibustion was adopted in the two groups. The mild suspended moxibustion was applied at two acupoints with the strongest thermosensitization. In the saturated moxa dosage group, the moxibustion time was determined by the disappearance of thermosensitization. In the regular moxa dosage group, 15 min was required on each acupoint. The treatment was given twice a day for first 4 days in the two groups. Since the 5th day, the treatment was given once a day, continuously for 10 times, and totally 14 days were required. The score of symptoms and function and clinical efficacy were compared between the two groups before and after treatment as well as 6-month follow-up after treatment.
RESULTSThe curative and effective rate was 56.7% (17/30) after treatment and 60.0% (18/30) in 6-month follow-up after treatment in the saturated moxa dosage group, which were superior to 26.7% (8/30) and 30.0% (9/30) in the regular moxa dosage group respectively (P < 0.01, P < 0.05). The scores of clinical symptoms and function after treatment and in follow-up were improved apparently as compared with those before treatment in both groups (all P < 0.01). The scores of clinical symptoms and function after treatment and in follow-up in the saturated moxa dosage group were increased much more apparently than those in the regular moxa dosage group (after treatment: 22.32 +/- 4.64 vs 17.43 +/- 3.21; in follow-up: 23.01 +/- 4.76 vs 18.32 +/- 2.13, both P < 0.01).
CONCLUSIONThe thermosensitization moxibustion of saturated dosage achieves the superior short-term and long-term efficacies in the treatment of CSA as compared with the regular moxibustion dosage.
Acupuncture Points ; Adult ; Female ; Humans ; Male ; Middle Aged ; Moxibustion ; instrumentation ; Spondylosis ; physiopathology ; therapy ; Vertebral Artery ; physiopathology
8.Effect of laser artificial shrinkage on pregnancy outcome in vitrification of human expanded blastocysts
Wen-Juan REN ; Juan-Zi SHI ; Ming-Zhao LI ; Si-Lin ZHANG ; Xia XUE ; Wan-Qiu ZHAO ; Hui-Hui HONG ; Dang-Xia ZHOU
Journal of Xi'an Jiaotong University(Medical Sciences) 2018;39(2):281-285
Objective To investigate the effect of laser artificial shrinkage(LAS)on pregnancy outcome in vitrification of human expanded blastocysts.Methods We selected 3859 frozen-thawed blastocyst-stage embryo transfers from January 2014 to December 2015.The transfers were divided into LAS group(n=3 176)and non-LAS group(n=683),which were then subdivided into <36 y subgroup and ≥36 y subgroup according to their age.Main outcomes measures were thawing rate,implantation rate and clinical pregnancy rate.Results Thawing rate, clinical pregnancy rate and implantation rate were 97.32%(5 453/5 603),66.81%(2 118/3 170),and 53.55%(2 912/5 438)in LAS group.In non-shrink group,they were 95.13%(1 173/1 233),62.70%(427/681),and 49.74%(582/1 170),which did not significantly differ from those in the former group(P<0.05).Further analysis of the subgroups showed that thawing rate was significantly higher in LAS group than in non-shrink group of patients<36 y(97.27% vs.95.33%;P<0.05).Thawing rate and biochemical pregnancy rate were significantly higher in LAS group than in non-shrink group in patients ≥36 y(97.75% vs.93.66%;65.45% vs.50.65%,P<0.05). Cancellation rate was not significantly different between the two groups(0.19% vs.0.29%, P > 0.05). Conclusion LAS technique can increase thawing rate,clinical pregnancy rate and implantation rate before cryopreservation of blastocysts.
9.Establishment and application of standard serum proteomic pattern for diagnosis of early liver cancer.
Ren CHEN ; Xiao-Ping CHEN ; Qiu-Qiong LIN ; Bing-Liang LIN ; Hui-Juan CAO
Journal of Southern Medical University 2011;31(2):341-343
OBJECTIVETo establish standard serum proteomic pattern for early liver cancer and explore its value in early liver cancer diagnosis.
METHODSThe serum samples were obtained from 12 healthy subjects and 12 patients with early liver cancer. After removal of serum albumin and IgG, 300 µg serum sample was mixed with the hydrating solution for two-dimensional gel electrophoresis. Each experiment was repeated for 3 times. With silver staining and image analysis, the differentially expressed proteins were identified to establish the standard proteomic pattern for early liver cancer. The proteomics pattern was then tested in the diagnosis of 13 cases of chronic liver disease and 10 healthy individuals in a double-blind manner.
RESULTSThirty-eight differentially expressed protein spots were identified. Eleven protein spots with differential expressions by over 5 folds were analyzed to establish the standard proteomics pattern for early liver cancer, which showed a sensitivity of 92% and specificity of 90% in early diagnosis of liver cancer.
CONCLUSIONThe standard serum 2-DE proteomic pattern for early liver cancer shows distinct differences from that of healthy subjects. The differentially expressed proteins and their specific combination pattern may have the potential for diagnosis and prognostic evaluation of early liver cancer.
Adult ; Biomarkers, Tumor ; blood ; Blood Proteins ; analysis ; Early Detection of Cancer ; methods ; Electrophoresis, Gel, Two-Dimensional ; methods ; Female ; Humans ; Liver Neoplasms ; blood ; diagnosis ; Male ; Middle Aged ; Proteome ; metabolism ; Proteomics ; methods
10.Effects of CpG-ODN combined with HBsAg on the phenotype, function and the activity of NF-kappa B and AP-1 of monocyte-derived dendritic cells in chronic hepatitis B patients.
Xiao-Xing XIANG ; Xia-Qiu ZHOU ; Qing XIE ; Hong YU ; Hui-Juan ZHOU
Chinese Journal of Hepatology 2008;16(2):97-100
OBJECTIVETo investigate the effect of synthetic non-methylated CpG-ODN combined with recombined HBsAg on the phenotype, function and the expression level of nucleic transcription factor NF-kappa B (NF-kB) and AP-1 of monocyte-derived dendritic cells (DC) in patients with chronic hepatitis B (CHB).
METHODSPurified monocytes were isolated from the peripheral blood of CHB patients and healthy volunteers and cultured with human granulocyte-monocyte colony stimulating factor added together with interleukin-4. On the fifth day of culture, CpG-ODN, HBsAg and other reagents, such as TNF alpha and PBS, were added to the medium, and 18 hours later cells were collected for the detection of surface molecules (HLA-DR/CD86/CD1a). IL-12p70 levels in the supernatant and stimulating capacity to allogenic T lymphocytes were detected. The nucleic proteins of NF-kB and AP-1 in DC were extracted and purified for the gel shift assay.
RESULTSCompared with those of the PBS group, the expression rates of HLA-DR of DC treated with CpG-ODN and/or HBsAg were obviously increased. Both the IL-12p70 level and the stimulating capacity of DC to allogenic T lymphocytes in mixed lymphocyte reaction increased significantly in the CpG-ODN group and in the CpG-ODN/HBsAg combination group (P less than 0.01 and 0.05, respectively). The expression rates of CD1a were raised only in the CpG-ODN/HBsAg combination group. Three kinds of immunological adjuvants, TNF alpha, CpG-ODN and CpG-ODN/HBsAg enhanced the expression of nucleic NF-kB and inhibited the expression of AP-1 in DC.
CONCLUSIONCpG-ODN, like TNF alpha, has remarkable stimulatory effect on the impaired phenotype and function of monocyte-derived DC in patients with CHB; CpG-ODN and HBsAg have a synergetic effect in increasing the antigen presenting function. The regulating ability of CpG-ODN and TNF alpha on the expression levels of NF-kB and AP-1 might be one of the mechanisms of their immunostimulatory effects on DC of the CHB patients.
Adjuvants, Immunologic ; pharmacology ; Adult ; Cells, Cultured ; Dendritic Cells ; metabolism ; HLA-DR Antigens ; metabolism ; Hepatitis B Surface Antigens ; pharmacology ; Hepatitis B, Chronic ; metabolism ; Humans ; Male ; NF-kappa B ; metabolism ; Oligodeoxyribonucleotides ; pharmacology ; Recombinant Fusion Proteins ; Transcription Factor AP-1 ; metabolism